Immunomedics adopts PleaseReview to accelerate documentation management

By Vassia Barba

- Last updated on GMT

(Image: Getty/nirat)
(Image: Getty/nirat)

Related tags Data management Immunomedics antibody-drug conjugates Antibody drug conjugates Antibody Data Software Clinical data Clinical data management Fda

Immunomedics to leverage Ideagen’s PleaseReview software service to support documentation management of its ADC development projects.

Built by software developer Ideagen, PleaseReview is an application that aims to simplify co-authoring and reviewing of documents produced for several purposes, including regulatory submissions and clinical data management.

According to Ideagen, the application also enables redaction of documents, in order to assist the users in protecting sensitive information.

US-based pharmaceutical company, Immunomedics, announced it will utilize the software service to support its development projects for candidates in oncology.

Kiyoung Hong, Immunomedics’ director of Regulatory Operations and Publishing, suggested that the adoption of the application is expected to be ‘extremely beneficial’ as the company looks to streamline its operations, adding that documentation review can often be “quite intense and time-consuming, with sometimes up to 50 authors and reviewers involved at any one time.”

Moreover, Hong noted that the company aims to initially use PleaseReview for its regulatory submission documents, however, over time the application will be integrated as the software for document reviews across the organization.

Earlier this year, Immunomedics experienced a regulatory blockage, with the FDA rejecting the biologics license application​ for its antibody-drug conjugate (ADC), sacituzumab govitecan, and then announcing instances of data integrity breaches and manipulation​ found during an inspection.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more